Acute sinusitis trials
On Oct. 29, the committee will discuss clinical design of studies for antimicrobials to treat acute bacterial sinusitis. FDA issued a draft guidance on acute bacterial sinusitis treatment in July 1998 (1"The Pink Sheet" July 27, 1998, p. 25). The meetings will be held at the Holiday Inn in Gaithersburg, Md. beginning at 8 a.m. on Oct. 28 and 8:30 a.m. on Oct. 29. [To 2watch a webcast or video of this meeting, go to FDAAdvisoryCommittee.com]...
You may also be interested in...
FDA has proposed a three-part staging system for Lyme disease in a draft guidance document released as part of a series of guidances on the development of antimicrobial drugs.
Teva has disclosed plans to focus on climate action and resilience, responsible use of natural resources and emissions, effluents and waste, as part of a long-term environmental sustainability commitment. Meanwhile, Hikma has at the same time committed “to further reducing our climate impact and improving the resilience of our business in the face of future climate change.”
Health technology assessment body NICE wants Kite to collect more evidence to prove that Tecartus can cure relapsed or refractory mantle cell lymphoma. But in the meantime, it says the CAR-T therapy should be made available on the National Health Service, making UK patients among the first in the world to be offered access to the treatment.